ORAMED PHARMACEUTICALS INC. Annual Income Tax Expense (Benefit) in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2022.
  • Oramed Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1.13M.
  • Oramed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $100K.
  • Oramed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2019 was $300K.
  • Oramed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2017 was $400K, a 70% decline from 2016.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $100K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2019 $300K Sep 1, 2018 Aug 31, 2019 10-K 2020-11-24
2017 $400K -$935K -70% Sep 1, 2016 Aug 31, 2017 10-K 2019-11-27
2016 $1.34M +$1.34M Sep 1, 2015 Aug 31, 2016 10-K 2018-11-28
2015 -$1K -$5K -125% Sep 1, 2014 Aug 31, 2015 10-K 2017-11-29
2014 $4K -$201K -98% Sep 1, 2013 Aug 31, 2014 10-K 2016-11-25
2013 $205K +$115K +128% Sep 1, 2012 Aug 31, 2013 10-K 2015-11-25
2012 $90K +$114K Sep 1, 2011 Aug 31, 2012 10-K 2014-11-14
2011 -$24K Sep 1, 2010 Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.